Retractable Technologies, Inc.

Retractable Technologies, Inc. (NYSE: RVP) manufactures and distributes VanishPoint and Patient Safe safety medical products and the EasyPoint needle. VanishPoint syringes, blood collection devices, and IV catheters are designed to reduce needlestick injuries and product reuse by extracting the needle immediately from the patient and successfully decreasing exposure to the contaminated needle. Patient Safe syringes are made to prevent bloodstream infections caused by contaminated catheter hubs. The simple point is a retractable needle that can deliver injections with a Luer lock, Luer slip, and prefilled syringes.

Why Should Investors Make An Exit?

• Weak Liquidity Profile: The company's current ratio at the end of FY21 is 2.96x, compared to the industry median of 3.72x. This implies relatively lackluster liquidity profile against the industry median.
• Supplier Concentration: Purchases from Chinese manufacturers accounted for 92.0% and 85.2% of RVP's total purchases in FY21 and FY20, respectively. As a result, delays in receiving the required quantity or unfavourable pricing from Chinese manufacturers may cause output to be distorted, compromising the company's overall operational situation.
• Technical weakness: On the daily chart, RVP price is trading below the downward sloping trend line and facing the resistance of the same. Furthermore, the momentum oscillator RSI (14-period) is trading at ~46.17 level, trading in negative territory. On the weekly chart the prices are trading below the trend-following indicators 50- period SMA, which may act as a resistance level for the stock. An important support level for the stock, is placed at USD 4.00 while the key resistance level is placed at USD 4.90.

Stock Recommendation:

RVP's share price has declined 59.26% in the past nine months and is currently leaning towards the lower band of the 52-week range of USD 4.26 to USD 13.91.

Considering the company's weak liquidity profile, current valuation and associated risks. we recommend a "Sell" rating on the stock at the current price of USD 4.49, down 1.10% as of April 12, 2022, at 08:07 AM PDT.

Three-Year Technical Price Chart (as of April 12, 2022, at 08:07 AM PDT). Source: REFINITIV, Analysis by Kalkine Group

* The reference data in this report has been partly sourced from REFINITIV.

* All forecasted figures and industry information have been taken from REFINITIV.

Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.